Selective anti-inflammatory therapy in infantile rheumatoid arthritis
Mignone, F.; Sardella, M.L.; Clara, L.; Barbero, I.; Bevivino, T.; Ciravegna, P.
Minerva Pediatrica 39(9): 403-408
1987
ISSN/ISBN: 0026-4946 PMID: 3627072 Document Number: 298201
Document emailed within 1 workday
Related Documents
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Rodríguez Moreno, J.; Valverde García, J.; Castelao, A.M.; Roig Escofet, D.; Juanola Roura, X.; Gil Suárez, M.L.; Belmonte Serrano, M. 1987: Renal insufficiency in rheumatoid arthritis. Effect of non-steroidal anti-inflammatory agents Medicina Clinica 89(8): 324-327
Kurowski, M.; Dunky, A. 1992: Transdermal absorption of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients: I. Diclofenac International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 479
Sigidin, I.A.; Pokryshkin, V.I. 1987: A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis Terapevticheskii Arkhiv 59(4): 73-76
Simon, L.S.; Weaver, A.L.; Graham, D.Y.; Kivitz, A.J.; Lipsky, P.E.; Hubbard, R.C.; Isakson, P.C.; Verburg, K.M.; Yu, S.S.; Zhao, W.W.; Geis, G.S. 1999: Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial JAMA 282(20): 1921-1928
Burmester, G.R.; Emmrich, F. 1993: Anti-CD4 therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 11(Suppl 8): S139-S145
Choy, E.H.; Kingsley, G.H. 1993: Anti-CD4 therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 11(Suppl 8): S147-S149
Van der Lubbe, P.A.; Reiter, C.; Riethmüller, G.; Breedveld, F.C. 1993: Anti-CD4 therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 11(Suppl 8): S151
Maini, R.N.; Brennan, F.M.; Williams, R.; Chu, C.Q.; Cope, A.P.; Gibbons, D.; Elliott, M.; Feldmann, M. 1993: TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy Clinical and Experimental Rheumatology 11(Suppl 8): S173-S175
Feldmann, M.; Brennan, F.; Paleolog, E.; Taylor, P.; Maini, R.N. 1997: Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action European Cytokine Network 8(3): 297-300
Straub, R.H.; Härle, P.; Atzeni, F.; Weidler, C.; Cutolo, M.; Sarzi-Puttini, P. 2005: Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy Journal of Rheumatology 32(7): 1253-1258
Svenson, K.L.; Lithell, H.; Hällgren, R.; Selinus, I.; Vessby, B. 1987: Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity Archives of Internal Medicine 147(11): 1912-1916
Antoni, C.; Kalden, J.R. 1999: Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 17(6 Suppl 18: S73-S77
Chiappo, G.F.; Mignone, F.; Balbo, L.; Sciolla, N.; Bertoletti, M.T.; Mostert, M. 1981: Current knowledge of the etiopathogenesis and classification of infantile rheumatoid arthritis Archivio Per le Scienze Mediche 138(3): 273-280
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Dombrecht, E.J.; Aerts, N.E.; Schuerwegh, A.J.; Hagendorens, M.M.; Ebo, D.G.; Van Offel, J.F.; Bridts, C.H.; Stevens, W.J.; De Clerck, L.S. 2006: Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis Clinical and Experimental Rheumatology 24(1): 31-37
Sun, J.; Zhang, Y.; Liu, L.; Liu, G. 2014: Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis Clinical and Experimental Rheumatology 32(1): 11-21
Lo, V.; Meadows, S.E.; Saseen, J. 2006: When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis? Journal of Family Practice 55(3): 260-262
Yamane, T.; Hashiramoto, A.; Tanaka, Y.; Tsumiyama, K.; Miura, Y.; Shiozawa, K.; Chihara, K.; Shiozawa, S. 2008: Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor Journal of Rheumatology 35(3): 414-420